LifeMD, Inc. (LFMDP) stock
LFMDPNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3099% above fair value
$21.65+0.13 (+0.60%)
Close on Oct 30, 2026Market cap $110.38MP/E –Yield –
LifeMD price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
LifeMD's price to sales ratio was 0.7× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.4× to 3.7×, with a median of 1.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.7× | −0.3 |
| 2025 | Dec 31, 2025 | 1.0× | −0.1 |
| 2024 | Dec 31, 2024 | 1.1× | −1.0 |
| 2023 | Dec 29, 2023 | 2.1× | +1.6 |
| 2022 | Dec 30, 2022 | 0.5× | −0.8 |
| 2021 | Dec 31, 2021 | 1.3× | −2.3 |
| 2020 | Dec 31, 2020 | 3.6× | +3.0 |
| 2019 | Dec 31, 2019 | 0.6× | −0.4 |
| 2018 | Dec 31, 2018 | 1.0× | −2.8 |
| 2017 | Dec 29, 2017 | 3.8× | +1.9 |
| 2016 | Dec 30, 2016 | 1.9× | −1.7 |
| 2015 | Dec 31, 2015 | 3.7× | −0.6 |
| 2014 | Dec 31, 2014 | 4.3× | −5.7 |
| 2013 | Dec 31, 2013 | 10.0× | – |